Bank of America’s Heart Test Laboratories HSCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26
Closed -$80 6242
2025
Q4
$80 Buy
26
+7
+37% +$21 ﹤0.01% 6865
2025
Q3
$66 Buy
19
+9
+90% +$33 ﹤0.01% 7945
2025
Q2
$38 Buy
10
+1
+11% +$3 ﹤0.01% 8154
2025
Q1
$25 Buy
9
+1
+13% +$3 ﹤0.01% 8091
2024
Q4
$31 Buy
8
+1
+14% +$3 ﹤0.01% 7948
2024
Q3
$34 Buy
7
+3
+75% +$11 ﹤0.01% 7887
2024
Q2
$21 Buy
+4
New +$32 ﹤0.01% 7996

Other funds holding HSCS

Bank of America's HSCS Position: Q1 2026 in Review

Bank of America sold out of Heart Test Laboratories (HSCS) in Q1 2026, closing a stake of 26 shares — an estimated $80 sold.

Bank of America first reported a position in HSCS in Q2 2024 and held it in 7 quarters. The position peaked at $80 in Q4 2025. 13 funds tracked by Wall St. Rank hold HSCS as of Q1 2026.

  • Bank of America reported no remaining Heart Test Laboratories position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 26 Heart Test Laboratories shares in Q1 2026, an estimated $80.
  • Bank of America first reported a position in Heart Test Laboratories in Q2 2024 and held it in 7 quarters.
  • Bank of America's Heart Test Laboratories position peaked at $80 in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.